2014
DOI: 10.1134/s1819712414040114
|View full text |Cite
|
Sign up to set email alerts
|

Peptide regulation of specific ligand-receptor interactions of GABA with the plasma membranes of nerve cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 32 publications
0
9
0
Order By: Relevance
“…The radioligands were checked for stability of their chemical structure within the incubation period (up to 120 min), using HPLС method of analysis. The characteristic of [ 3 H]GABA specific binding to rat brain cells' plasmatic membranes was obtained in our previous study; within the present experimental conditions, we got the same results (Table ). Two sites of [ 3 H]GABA specific binding were found in all the tested brain structures (hippocampus, cerebellum, cortex, and basal nuclei) and characterized by the same affinity.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The radioligands were checked for stability of their chemical structure within the incubation period (up to 120 min), using HPLС method of analysis. The characteristic of [ 3 H]GABA specific binding to rat brain cells' plasmatic membranes was obtained in our previous study; within the present experimental conditions, we got the same results (Table ). Two sites of [ 3 H]GABA specific binding were found in all the tested brain structures (hippocampus, cerebellum, cortex, and basal nuclei) and characterized by the same affinity.…”
Section: Resultsmentioning
confidence: 99%
“…Each biologically active neuropeptide is characterized by a unique spectrum of molecular receptor and physiological activity. For example, in contrast to Semax (nootropic and neuroprotector), peptide anxiolytic Selank potentiates the binding of [ 3 H]GABA in the presence of peptide molecules (“in vitro”) and increases the number of [ 3 H]GABA binding sites after pre‐introduction . Somatostatin, depending on its concentration, is able to modulate (potentiate or inhibit) ion currents of rat hippocampal neurons glutamate and GABA receptors …”
Section: Discussionmentioning
confidence: 99%
“…This difference in the number of genes whose expression changed suggests that Selank acts not directly through the center of the specific binding of GABA, but rather allosterically by altering the affinity of the GABA receptor for GABA. Previously, it was shown that Selank is able to affect the specific binding of GABA to its own receptors, which may be caused by modulating properties of regulatory peptide, which apparently change the affinity of endogenous ligands under the influence of Selank on the receptor (V'Yunova et al, 2014 ). We can assume that the observed similarity of expression profiles of our study genes after administration of Selank and GABA partly confirms the hypothesis about the possible effect of the peptide through the regulation of the activity of GABA A receptors.…”
Section: Discussionmentioning
confidence: 99%
“…Previously, it was shown that in the presence of Selank the amount of the specifically bound ligand, [ 3 H] GABA, varied, and preliminary intranasal administration of peptide also induced changes in the number of specific binding sites of [ 3 H] GABA but did not affect the affinity of the receptors (V'Yunova et al, 2014 ). Based on these data, the authors suggested that Selank can lead to a rapid change in the state of the GABAergic system by binding the peptide to GABA receptors and, thus, allosterically modulating the activity of GABA A receptor.…”
Section: Introductionmentioning
confidence: 99%
“…Clinical studies have shown that the anxiolytic effect of Selank is comparable to the effect of low doses of the benzodiazepine tranquilizers; however, the action of Selank is not accompanied by the characteristic side effects of those drugs [ 9 , 10 ]. Furthermore, Selank affects the specific binding of GABA to GABA A receptors, which may be caused by a change in affinity of endogenous ligand receptors under the action of Selank [ 11 ]. This suggests that the presence of Selank may change the action of classical BZD.…”
Section: Introductionmentioning
confidence: 99%